Mycological infections

Mycological infections, caused by pathogenic fungi, range from superficial skin conditions to life-threatening systemic mycoses, especially in immunocompromised patients. Early and accurate identification of fungal pathogens is essential for appropriate antifungal therapy and reducing complications in critical care and transplant settings.
Mycological infection PCR kits based on real-time PCR technology provide a sensitive and specific method for detecting fungal DNA in human samples. These molecular diagnostics tools offer accurate and reproducible results in routine and specialized laboratory workflows, and cover a wide range of clinically relevant fungi, including Candida albicans, Candida glabrata, Candida auris, Candida tropicalis, Candida dubliniensis, Candida parapsilosis, Clavispora lusitaniae (Candida lusitaniae), Debaryomyces hansenii (Candida famata), Kluyveromyces marxianus (Candida kefyr), Malassezia furfur / Malassezia species, Meyerozyma guilliermondii (Candida guilliermondi), Pichia kudriavzevii (Candida krusei), and Saccharomyces cerevisiae. Available in CE IVD-marked formats for diagnostic use and research use only (RUO) versions, these PCR assays support applications in invasive fungal infection (IFI) diagnostics, antifungal stewardship, and high-risk patient monitoring from clinical samples.